Home › Idiopathic Thrombocytopenic Purpura › Washington › Seattle
Idiopathic Thrombocytopenic Purpura clinical trials in Seattle, WA
4 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- University of Washingto, Seattle
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
RecruitingPhase 2
- Fred Hutchinson Cancer Center, Seattle
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- University of Washingto, Seattle
OM336 in Autoimmune Cytopenias
RecruitingPhase 1
- Fred Hutchinson Cancer Center, Seattle
Idiopathic Thrombocytopenic Purpura trials in other cities
- Los Angeles, CA7 studies
- Washington, DC6 studies
- Greenville, NC6 studies
- Boston, MA6 studies
- The Bronx, NY5 studies
- Durham, NC4 studies
- Rochester, MN4 studies
- Portland, OR4 studies
- Houston, TX4 studies
- Cedar Rapids, IA3 studies
- Cleveland, OH3 studies
- New Orleans, LA3 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)49 studies
- Prostate Cancer42 studies
- Acute Myeloid Leukemia41 studies
- Breast Cancer39 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer30 studies
- Multiple Myeloma22 studies
- Bladder Cancer21 studies
- Myelodysplastic Syndromes21 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.